Differential effects of CCK-JMV-180 on food intake in rats and mice

@article{Asin1992DifferentialEO,
  title={Differential effects of CCK-JMV-180 on food intake in rats and mice},
  author={K. Asin and L. Bednarz},
  journal={Pharmacology Biochemistry and Behavior},
  year={1992},
  volume={42},
  pages={291-295}
}
  • K. Asin, L. Bednarz
  • Published 1992
  • Biology, Medicine
  • Pharmacology Biochemistry and Behavior
    • Boc-Tyr(SO3)-Nle-Gly-Trp-Nle-Asp-2-phenylether ester (CCK-JMV-180) has been reported to be a CCK-based heptipeptide with novel in vitro properties. Based on studies conducted in rat and mouse pancreatic acini, it has been proposed that the compound acts as an agonist at the high-affinity site and an antagonist at the low-affinity site in the rat, but as an agonist at both sites in the mouse. In the present study, we examined the effects of CCK-JMV-180 on locomotor activity in the rat and on… CONTINUE READING
    View on Elsevier
    doi.org
    22 Citations
    Background Citations
    5
    22 Citations
    Citation Type

    Citation Type

    The third intracellular loop of the rat and mouse cholecystokinin-A receptors is responsible for different patterns of gene activation.
    • 11
    • PDF
    Effects of CCK‐A Antagonist Devazepide on Inhibition of Feeding by Duodenal Infusion of Oleic Acid in Rats
    • 8
    Cholecystokinin inhibits gastric emptying and contracts the pyloric sphincter in rats by interacting with low affinity CCK receptor sites
    • 49
    Whole body autoradiography of CCK-8 in rats
    • 19
    Cholecystokinin and satiety: current perspectives.
    • 246
    Actions of CCK in the controls of food intake and body weight: Lessons from the CCK-A receptor deficient OLETF rat
    • 88
    Is the CCK2 receptor essential for normal regulation of body weight and adiposity?
    • 23
    Characterization of type A and type B CCK receptor binding sites in rat vagus nerve
    • 141
    CCK‐JMV‐180 acts as an antagonist of the CCKA receptor in the human IMR‐32 neuroblastoma cell line
    • 6
    SR146131: a new potent, orally active, and selective nonpeptide cholecystokinin subtype 1 receptor agonist. I. In vitro studies.
    • 33
    • PDF

    References

    SHOWING 1-10 OF 13 REFERENCES
    Comparative activity of two cholecystokinin analogues with partial agonist activity: Effects on food intake and brain monoamines
    • 6
    CCK-JMV-180: a peptide that distinguishes high-affinity cholecystokinin receptors from low-affinity cholecystokinin receptors.
    • 70
    Receptor occupation, calcium mobilization, and amylase release in pancreatic acini: effect of CCK-JMV-180.
    • 71
    A new CCK analogue differentiates two functionally distinct CCK receptors in rat and mouse pancreatic acini.
    • 46
    Structure-activity relationship studies on cholecystokinin: analogues with partial agonist activity.
    • 66
    Relationship of cholecystokinin receptor binding to regulation of biological functions in pancreatic acini.
    • 73
    Binding of cholecystokinin to high affinity receptors on isolated rat pancreatic acini.
    • 246
    • PDF
    Obese male mice (ob/ob) are normally sensitive to the satiating effect of CCK-8
    • 12
    Experimental pancreatitis is mediated by low-affinity cholecystokinin receptors that inhibit digestive enzyme secretion.
    • 100
    • PDF
    Evidence that decreased feeding induced by systemic injection of cholecystokinin is mediated by CCK-A receptors.
    • 102